BIT
Click for more information
2.22% 4.6¢ biotron limited

$10 Billion Deal, page-12434

  1. Fingers xed
    7,600 Posts.
    lightbulb Created with Sketch. 959
    clock Created with Sketch.
    09/05/24
    08:27
    Post #: 73737713

    Hepatitis C Market Forecast 2032: FDA, EMA, PDMA Approvals, Epidemiology, Therapies, Clinical Trials and Companies by DelveInsight | BMS, Merck, Roche, Gilead Sciences, Johnson & Johnson, Abbvie

    https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/26038163/hepatitis-c-market-forecast-2032-fda-ema-pdma-approvals-epidemiology-therapies-clinical-trials-and-companies-by-delveinsight-bms-merck-roche-gilead-sciences-johnson-johnson-abbvie/
    BIT Price at posting: 6.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

RDN If you thought lithium was dead, think again. The Pilbara will be central to the next upswing
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
NEWS From the Floor: Gold questions answered...
right-arrow Created with Sketch.
GYG Guzman Y Gomez shot up nearly 40% in first hour of trades. Can it last?
right-arrow Created with Sketch.
NEWS Chris Judd's Talk Ya Book: Tracking Life360 on a journey to the stars
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
4.6¢ 		Change
0.001(2.22%) 		Mkt cap ! $41.50M
Open High Low Value Volume
4.4¢ 4.7¢ 4.4¢ $31.64K 708.3K

Buyers (Bids)

No. Vol. Price($)
4 259000 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 17361 1
View Market Depth
Last trade - 14.10pm 21/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.